Managers
Ardian’s latest cycle of fundraising has attracted investment of USD14 billion, comprising USD10.8 billion from Ardian’s seventh generation secondary platform and USD3.2 billion of primary investments.
This comes less than two years after Ardian raised USD10 billion through its previous round of fundraising. Ardian has now raised USD27.4 billion for secondary investment in under five years.
This latest round of fundraising confirms Ardian as a global leader in Funds of Funds, attracting major institutional investors from North America, Europe, the Middle East, Asia and South America. In total, this amounts to 180 investors from 26 different countries. Around 25 per
Monroe Capital has acted as sole lead arranger and administrative agent on a USD63 million senior credit facility to support an investment in Familia Dental Group Holdings (Familia) by private equity sponsor, The Halifax Group.
Headquartered in suburban Chicago, Familia provides quality, affordable dental care to underserved populations in smaller markets across five states. The company provides general dentistry, orthodontics and oral surgery services to over 250,000 patients annually.
The business was founded in 2008 and now has 31 clinics, half of them in the Upper Midwest, with several expected openings slated for later this year.
The Association of International Wealth Management of India (AIWMI), in conjunction with a number of big-name fund houses, has set up the Indian Association of Alternative Investment Funds (IAAIF).
IAAIF aims to set standards and provides a voice for the emerging alternative investments sector in India.
The current Charter Members of IAAIF are Ambit Investment Advisors, Arthveda, Ativir, DSP Blackrock Investment Managers, Edelweiss Alternative Asset Advisors, Harmony Capital, India Infoline Asset Management, IFMR Investment Managersand Unifi Capital, with many other institutions currently in the on-boarding stage. Current Affiliate Members are Milesoft Technologies & Amicorp Trustees.
India’s alternative investment funds (AIFs),
Ogier has assisted Medicxi Ventures, formerly Index Ventures Life Sciences, with its formation as an independent life sciences firm. Medicxi Ventures comprises all of the existing life sciences portfolio companies, funds and team from Index Ventures.
The Ogier team also worked with Medicxi Ventures on the establishment of Medicxi Ventures I, a new fund focused on early-stage life sciences investments in Europe, which has raised 210 million euros with GlaxoSmithKline and Johnson & Johnson Innovation-JJDC Inc. The closing of Medicxi Ventures I consolidates the position of Medicxi Ventures as one of the largest life sciences focused venture firms in Europe.
Quercus Assets Selection and Swiss Life Asset Managers have completed a deal to acquire Antin Solar Investments (ASI) in a 50:50 joint venture. ASI now operates as Azienda Solare Italiana Spa.
On 18 December 2015 the joint venture, called Quercus Swiss Life Italian Solar Srl, had entered into a binding agreement with Antin Infrastructure Partners to acquire a 100 per cent stake in ASI.
Founded in 2011, ASI has become a leading photovoltaic (PV) investment platform in Italy. The portfolio today consists of nine plants with a total installed capacity of 77.1 MW, and is the fifth largest operator in
Speyside Private Fund Advisers, a special situations buyout firm, has held the closing of Speyside Equity Fund I, a USD130 million buyout fund that will focus on investment opportunities in specialty chemicals, industrials/metal forming & food ingredients businesses and continue the disciplined investment approach that Speyside has successfully executed for the past 10 years.
Investors in Speyside Equity Fund I LP include a blue chip roster of leading institutional limited partners such as, endowments, foundations, insurance companies, fund of funds, public and private pensions, and family offices. The Fund was closed in less than 4 months of fundraising and was
G-Therapeutics has secured up to EUR26 million in a Series A financing round from an investment syndicate consisting of Gimv, Wellington Partners, LSP and Inkef Capital alongside the company’s founders/management.
This investment will fund the company’s clinical trials up to CE mark (EU) and IDE (US) approval.
G-Therapeutics (http://gtherapeutics.com/#About) develops an implantable neuro stimulator for patients with incomplete spinal cord injury. The company’s device supports motor function recovery for better and faster rehabilitation by stimulating the spinal cord. The company was founded in 2014 as a spin-off of the Center for Neuro-Prosthetics of the renowned École Polytechnique Fédérale de Lausanne
BFF Nonwovens has secured a multi-million pound funding package from BGF (Business Growth Fund) and Lloyds Bank to pursue its growth ambitions in the UK and overseas.
Based in Bridgwater, Somerset, the company specialises in the production of high quality, bespoke technical fabrics for niche markets. Its products have a range of different end uses including filtration, packaging, acoustics and advanced wound care. BFF has invested in its manufacturing facilities to provide capacity across all of its product lines in both its Bridgwater and Bolton sites.
Under the leadership of David Lamb, Andrew Brownlow and Chris Burhop, the business has
Chemical technology company Avantium has closed a financing round of EUR20 million led by PMV, an independent investment company for Flanders, FPIM, a Belgian Federal Holding and Investment Company, and Avantium’s existing shareholders.
The funds will be used to commercialize the YXY technology for producing 100 per cent biobased packaging material PEF (polyethylenefuranoate), a next generation plastic with superior performance.
Avantium’s roll-out plan includes the construction of a ‘reference plant’, the world’s first commercial plant to produce FDCA (furandicarboxylic acid). This reference plant with a capacity of up to 50,000 metric tons per year is intended to be located in
The Chartered Alternative Investment Analyst (CAIA) Association, a global leader in alternative investment education, has embarked on its first international branding campaign.
Titled “Mind the Gap,” CAIA’s new campaign incorporates creative advertising in the London Underground system, social media outreach to CAIA Members and prospective Members, and educational events designed to help professionals in various alternative investing disciplines better understand the changing nature of the space and the ways in which education can help them build and maintain the relevant skills, while advancing their careers.
“We chose to launch the Mind the Gap campaign in London since it is
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
